Spectroscopic studies have been performed to investigate the high-affinity binding site for copper in human serum albumin (HSA) and dog serum albumin (DSA). A new approach based on exposure to albumin of the copper in the form of a well-characterized histidine (his) chelate has been adopted. This technique has been shown to minimize interaction at the lower affinity sites. The analysis of the S-band EPR spectrum of [Cu(his) 2 ] at pH 7.3 revealed the major component is a complex formed with two histidines in a histamine-like coordination. Detailed analysis of S-band and X-band EPR and optical spectra of [Cu(II)−HSA] revealed that copper forms a complex with HSA involving α -NH 2 terminal, two deprotonated peptide nitrogens (NH of Ala2, and NH of His3), and the imidazole nitrogen of His3 in a square planar arrangement. The spectral data were found to be independent of pH in the range 4.5−9.0 and did not confirm axial Asp1 carboxylate chelation. The EPR study of [Cu(II)−DSA] complex at pH 7.3 confirmed the presence of two bonded nitrogens which substantiate the absence of strategically located His3. It has been suggested that residues of non-nitrogen origin localized in the main body of DSA may be involved in copper binding, which would explain the protection from the Sanger reaction.
No takes yet. Share an insight, caveat, or question.
Valko et al. (1999) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: